- The Citagenix Clinical Report
- Issue 1
- Issue 2
- Issue 3
- Issue 4
- Issue 5
- Issue 6
- Issue 7
We have created this forum for our clinicians to share case reports that are of interest to us all.
We can notify you of the latest Citagenix Clinical Report as soon as it is available.
The Citagenix clinical Report, Issue 1
Endosseous dental implants are a predictable modality of tooth replacement that can improve the dental health and quality of life for many people. However, there is often inadequate bone to receive and support implants. This can be the result of trauma, periodontal disease, endodontic infection, postextraction ridge defects, disuse atrophy, etc. Therefore, guided bone regenerative procedures (GBR) have evolved to be an integral and predictable component of implant dentistry, either in preparation for, or in conjunction with, implant placement.
The Citagenix clinical Report, Issue 2
Maxillary and mandibular osseous reconstruction is often necessary to aid the prosthetic rehabilitation of many types of patients. These include post-traumatic, atrophic and post-ablative defects. In these as well as other guided bone regeneration procedures, readily available and predictable materials can expand the surgeon's choices in treatment planning. As the following Case Report indicates, a mixture composed of autogenous bone and DynaGraft Putty demineralized bone matrix (DBM) in a reverse phase medium, (Citagenix Inc. Montreal, Quebec) has shown promise for use in horizontal maxillary alveolar ridge reconstruction.
Products used: DynaGraft
The Citagenix clinical Report, Issue 3
Autogenous Bone Graft Harvesting for Implant Dehiscence Defect
Dr. Doug-Seok Sohn, Associate Professor, Chair Department of Oral and Maxillofacial Surgery Daegu Catholic University Hospital, Daegu, South Korea
While autogenous bone remains the "Gold Standard" for many implant related hard tissue grafting cases, there remains several drawbacks related to typical harvesting procedures. Patient dependant factors such as anatomical differences limiting access and poor bone quality cannot be controlled, yet there are several tools and techniques available to the dental clinician to help reduce donor site morbidity and surgical harvesting time.
Products used: Neomem
The Citagenix clinical Report, Issue 4
Sinus elevations are an accepted treatment modality to provide sufficient vital bone for the fixation of dental implants. Many edentulous posterior maxillas are subject to alveolar ridge resorption and increased pneumatization of the sinus. The classical sinus elevation with simultaneous implant placement is indicated where there is adequate ridge height and volume to achieve primary stability of the implants.
Products used: DynaGraft, Inion
The Citagenix clinical Report, Issue 5
Guided Tissue Regeneration (GTR) can promote or guide the proliferation of periodontal ligament cells and attachments onto denuded root surfaces. The use of a biocompatible, resorbable membrane provides for the extensive regeneration of the attachment apparatus without the interference of faster regenerating epithelial cells. This is a form of selective cell repopulation. The use of DFDBA ( Demineralized Freeze Dried Bone Allograft) materials can add an osteoconductive and osteoinductive component to facilitate the bone regeneration process.
The Citagenix clinical Report, Issue 6
This case study demonstrates immediate placement of implants in conjunction with a sinus elevation procedure utilizing a bone graft substitute.
Products used: DynaBlast
The Citagenix clinical Report, Issue 7
This case illustrates immediate placement of implants in conjunction with a sinus elevation procedure facilitated by a bone graft substitute.
Products used: DynaBlast